Gastrointestinal parasite fauna of Emperor Penguins (Aptenodytes forsteri) at the Atka Bay, Antarctica.

In general, the knowledge on parasites infecting Antarctic birds is scarce. The present study intends to extend the knowledge on gastrointestinal parasites of Emperor Penguins (Aptenodytes forsteri) at the Atka Bay, Antarctica. Fecal samples of 50 individual Emperor Penguins were collected at the Atka Bay and analyzed using the sodium-acetate-formaldehyde (SAF) method for the identification of intestinal helminth eggs and/or protozoan parasite stages. In addition, coproantigen ELISAs were performed to detect Cryptosporidium and Giardia infections. Overall, 13 out of 50 penguins proved parasitized (26%). The following stages of gastrointestinal parasites were identified: One Capillaria sp. egg, Tetrabothrius spp. eggs, Diphyllobothrium spp. eggs, and proglottids of the cestode Parorchites zederi. The recorded Capillaria infection represents a new host record for Emperor Penguins. All coproantigen ELISAs for the detection of Cryptosporidium spp. and Giardia spp. were negative. This paper provides current data on parasites of the Emperor Penguin, a protected endemic species of the Antarctica.

[Presentation of software for collation of inpatient diurnal pressure profiles in glaucoma patients]. / Vorstellung einer Software zur Erfassung von stationären Tagesdruckprofilen bei Glaukompatienten.

The aim of diurnal pressure profiles is clarification of therapy safety and the diagnosis of glaucoma. The evaluation of intraocular pressure curves is part of the running assessment. In order to support this evaluation software has been developed which, in addition to the digital presentation of intraocular pressure curves corrected for corneal thickness also allows immediate statistical assessment. After specifying a target pressure it also allows deduction of possible therapy recommendations based on the resulting intraocular pressure values, the cup/disc ratio and the number of antiglaucoma agents given. In this study two collectives were investigated: in the first collective, in addition to the previously determined diagnoses, the intraocular pressure, number and time of measurements, predetermined target pressure, cup/disc ratio and corneal thickness-dependent correction values were evaluated. After completing a scoring system with respect to agreement of the clinical therapy suggestions with those suggestions calculated by the software, the second collective was compared after termination of the diurnal pressure profile. Concordance was found in 73 out of 88 eyes. The digital collation system for profile measurement was found to be very well suited for graphical and clinical documentation of diurnal pressure profile curves. Therapy decisions can be deduced from the available data and supported by the software.

[Intravitreal bevacizumab for chronic central serous chorioretinopathy]. / Intravitreales Bevacizumab bei chronischer Retinopathia centralis serosa.

Central serous chorioretinopathy (CSCR) can lead to permanent visual loss in chronic cases. We report on a 57-year-old female patient with persistent findings over 6 months despite conservative therapy. A single intravitreal injection of bevacizumab led to a rapid morphologic and functional restitution without relapse or complication during the 19 weeks period after injection. Intravitreal injection of bevacizumab could be a therapeutic option for the treatment of chronic CSCR, however the results of appropriate studies must be awaited before it can be introduced into routine use.

Healon5 versus Viscoat during cataract surgery: intraocular pressure, laser flare and corneal changes.

BACKGROUND: The use of a viscoelastic substance facilitates cataract surgery. Healon 5 is a new viscoelastic product with special rheological properties. We evaluated the postoperative effect of Viscoat and Healon5 on intraocular pressure (IOP), central corneal thickness (CCT), endothelial cell counts and laser flare. METHODS: Forty-eight eyes of 48 patients undergoing routine phacoemulsification followed by foldable IOL implantation were enrolled. Either Healon5 or Viscoat was used according to a block-randomization scheme. The aspiration technique was standardized. IOP, CCT, endothelial cell counts and laser flare were compared pre- and postoperatively. Statistical analysis was performed using the two-sample Wilcoxon test. Data description was based on median and quartiles, while graphic description was performed by non-parametric box plots. RESULTS: Viscoat demonstrated a statistically significant higher IOP than Healon5 at 4 and 8 h postoperatively (P< 0.01 and < 0.05, respectively). Further, the laser flare values were statistically significantly higher for the Viscoat than for the Healon5 group 8 h postoperatively (P<0.05). Endothelial cell loss did not differ significantly between the two groups (relative change in endothelial cell density after 3 months: -4.3% for the Healon5 group and -6.2% for Viscoat group). CONCLUSION: There was neither a statistically nor a clinically significant difference in endothelial cell loss after the use of Healon5 or Viscoat in routine cataract surgery. However, the IOP in the early postoperative period was higher in the Viscoat group than in the Healon5 group.

Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.

The current study was carried out to elucidate the immunoregulatory changes induced by venom immunotherapy (VIT) in bee or wasp allergic subjects. All subjects included in this study had a history of severe systemic allergic reactions to stings of the respective insect as well as positive skin tests with the respective venom or venom-specific IgE in the sera. Parameters assessed in peripheral blood mononuclear cells (PBMC) before and after initiation of VIT (rush therapy reaching a maintenance dose of 100 micrograms venom injected subcutaneously within 1 week) were expression of CD3, CD4, CD8, CD45RA, CD45RO, interleukin (IL)-2 receptor (R) alpha, IL-4R, IL-12R, Fc epsilon RII, CD40, and CD40 ligand (CD40L), cells producing interferon (IFN)-gamma and IL-10 after stimulation with phorbol 12-myristate 13-acetate + ionomycin in the presence of monensin measured by flow cytometry; secretion of IFN-gamma, IL-4, and IL-10 measured by ELISA (IFN-gamma and IL-10 were additionally measured by PCR), and proliferation after stimulation with the respective venom. Significant decreases were observed after VIT for proliferative response to venom and venom + IL-4, IL-4 secretion, Fc epsilon RII, CD40, and CD40L expression. Significant increases were observed after VIT for IFN-gamma concerning the amount secreted and the number of producing cells, and IL-10, IL-10 was mainly produced by CD4+ cells that were negative for IFN-gamma, but some double-positive (IL-10 and IFN-gamma) cells were always detected. Addition of blocking anti-IL-10 antibodies, but not isotype control antibodies, prevented down-regulation of proliferation (but not IL-4 secretion) and further enhanced IFN-gamma secretion after VIT. These data indicate that in insect venom allergic subjects, VIT not only induces a rapid shift in cytokine expression from Th2 to Th1 cytokines, but also leads to induction of the immunosuppressive cytokine IL-10, which may be important for the limitation of potentially harmful allergen-specific Th1 responses. The described changes in cytokine expression may be responsible for subsequent increases in allergen-specific IgG and decreases in IgE production, as well as suppressive activity observed in earlier studies.